Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Wells

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Using siRNA knockdown in HaCaT cells to study transcriptional control of epidermal proliferation potentialJulie Wells, Xing Dai
Methods (San Diego, Calif.)|June 11, 2002
Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitationJulie Wells, Peggy J Farnham
Journal of Primary Health Care|December 20, 2024
Managing medicines-related continuity of care: the views of a range of prescribers in New Zealand general practiceC Julie Wells, Lynn McBain, Lesley Gray
Biochimica Et Biophysica Acta|October 20, 2006
Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermisAndy Teng, Mahalakshmi Nair, Julie Wells, et al.
Oncogene|March 12, 2003
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phaseJulie Wells, Pearlly S Yan, Meredith Cechvala, et al.
Current Clinical Pharmacology|January 28, 2012
Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumorsNirit Yarom, David Stewart, Rajesh Malik, et al.
Anticancer Research|November 24, 2011
ADH-1 in the treatment of metastatic adrenocortical carcinoma--case reportNirit Yarom, David Stewart, Leonard Avruch, et al.
Molecular Cancer Research : MCR|June 24, 2010
The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytesJulie Wells, Miguel N Rivera, Woo Jae Kim, et al.
International Journal of Nursing Education Scholarship|August 5, 2019
Identifying Indicators of National Council Licensure Examination for Registered Nurses (NCLEX-RN) Success in Nursing Graduates in Newfoundland & LabradorApril D Pike, Julia Lukewich, Julie Wells, et al.
Cancer Research|November 3, 2004
SUMO-1 modification of the Wilms' tumor suppressor WT1Gromoslaw A Smolen, Maria T Vassileva, Julie Wells, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Using siRNA knockdown in HaCaT cells to study transcriptional control of epidermal proliferation potentialJulie Wells, Xing Dai
Methods (San Diego, Calif.)|June 11, 2002
Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitationJulie Wells, Peggy J Farnham
Journal of Primary Health Care|December 20, 2024
Managing medicines-related continuity of care: the views of a range of prescribers in New Zealand general practiceC Julie Wells, Lynn McBain, Lesley Gray
Biochimica Et Biophysica Acta|October 20, 2006
Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermisAndy Teng, Mahalakshmi Nair, Julie Wells, et al.
Oncogene|March 12, 2003
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phaseJulie Wells, Pearlly S Yan, Meredith Cechvala, et al.
Current Clinical Pharmacology|January 28, 2012
Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumorsNirit Yarom, David Stewart, Rajesh Malik, et al.
Anticancer Research|November 24, 2011
ADH-1 in the treatment of metastatic adrenocortical carcinoma--case reportNirit Yarom, David Stewart, Leonard Avruch, et al.
Molecular Cancer Research : MCR|June 24, 2010
The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytesJulie Wells, Miguel N Rivera, Woo Jae Kim, et al.
International Journal of Nursing Education Scholarship|August 5, 2019
Identifying Indicators of National Council Licensure Examination for Registered Nurses (NCLEX-RN) Success in Nursing Graduates in Newfoundland & LabradorApril D Pike, Julia Lukewich, Julie Wells, et al.
Cancer Research|November 3, 2004
SUMO-1 modification of the Wilms' tumor suppressor WT1Gromoslaw A Smolen, Maria T Vassileva, Julie Wells, et al.
Pageof 3